Literature DB >> 14005852

An evaluation of 5-fluorouracil in malignant disease.

A J WEISS, L G JACKSON, R CARABASI.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/therapy; URACIL/related compounds

Mesh：

Substances：

Year:  1961        PMID： 14005852     DOI： 10.7326/0003-4819-55-5-731

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  Stress erosions. A major cause of gastrointestinal hemorrhage in patients with malignant disease.

Authors:  M S Klein; F Ennis; P Sherlock; S J Winawer
Journal:  Am J Dig Dis       Date:  1973-03

Review 2.  Cancer chemotherapy--the first twenty-five years.

Authors:  R B Scott
Journal:  Br Med J       Date:  1970-10-31

Review 3.  Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Report of five cases and review of the literature.

Authors:  H M Brink; L V Beex
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

Review 4.  Chemotherapy in the management of invasive bladder cancer. A review.

Authors:  H Bush; N Thatcher; R Barnard
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 5.  Optic neuropathy in cancer patients. Report of a case possibly related to 5 fluorouracil toxicity and review of the literature.

Authors:  L Delval; J Klastersky
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

6.  A REPORT OF THE SYSTEMIC USE OF 5-FLUOROURACIL IN THE TREATMENT OF CHINESE CANCER PATIENTS.

Authors:  D P CHAN; J H HO; A W WOO
Journal:  Br J Cancer       Date:  1964-03       Impact factor: 7.640

7.  Bilateral optic disc oedema and associated optic neuropathy in the setting of FOLFOX chemotherapy.

Authors:  Liam D Turner; John D Harrison
Journal:  BMC Ophthalmol       Date:  2013-08-08       Impact factor: 2.209
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.